Subclinical carotid atherosclerosis: Short-term natural history of lipid-rich necrotic core-A multicenter study with MR imaging

Radiology

Volumn 268, Issue 1, 2013, Pages 61-68

  Sun, Jie ^a   Balu, Niranjan ^a   Hippe, Daniel S ^a   Xue, Yunjing ^c   Dong, Li ^d   Zhao, Xihai ^e   Li, Feiyu ^f   Xu, Dongxiang ^a   Hatsukami, Thomas S ^b   Yuan, Chun ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Union Hospital   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Tsinghua University   (China)

^f PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PLACEBO;

ADULT; ARTERY DIAMETER; ARTERY WALL; ARTICLE; CAROTID ARTERY BIFURCATION; CAROTID ATHEROSCLEROSIS; CLINICAL EXAMINATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HISTORY; HUMAN; IMAGE ANALYSIS; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCLINICAL CAROTID ATHEROSCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAROTID STENOSIS; CONTRAST MEDIA; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LINEAR MODELS; LIPIDS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECROSIS; PLACEBOS; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 84879931199     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13121702     Document Type: Article

References (41)

1. Nicholls SJ, Hsu A, Wolski K, et al. Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol 2010;55(21):2399-2407.
2. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011;364(3): 226-235.
3. Underhill HR, Yuan C, Yarnykh VL, et al. Arterial remodeling in [corrected] subclinical carotid artery disease. JACC Cardiovasc Imaging 2009;2(12):1381-1389.
4. DeFilippis AP, Blaha MJ, Ndumele CE, et al. The association of Framingham and Reynolds risk scores with incidence and progression of coronary artery calcification in MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2011;58(20):2076-2083.
5. Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350(15):1495-1504.
6. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291(9):1071-1080.
7. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316(22): 1371-1375.
8. Von Birgelen C, Hartmann M, Mintz GS, et al. Spectrum of remodeling behavior observed with serial long-term (./ = 12 months) follow-up intravascular ultrasound studies in left main coronary arteries. Am J Cardiol 2004; 93(9):1107-1113.
9. Serruys PW, García-García HM, Buszman P, et al. Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 2008;118(11):1172-1182.
10. van Gils MJ, Vukadinovic D, van Dijk AC, Dippel DW, Niessen WJ, van der Lugt A. Carotid atherosclerotic plaque progression and change in plaque composition over time: a 5-year follow-up study using serial CT angiography. AJNR Am J Neuroradiol 2012;33(7):1267-1273.
11. Cai JM, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005;112(22):3437-3444.
12. Takaya N, Cai JM, Ferguson MS, et al. Intra-and interreader reproducibility of magnetic resonance imaging for quantifying the lipid-rich necrotic core is improved with gadolinium contrast enhancement. J Magn Reson Imaging 2006;24(1):203-210.
13. Takaya N, Yuan C, Chu BC, et al. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a highresolution magnetic resonance imaging study. Circulation 2005;111(21):2768-2775.
14. Sun J, Underhill HR, Hippe DS, Xue Y, Yuan C, Hatsukami TS. Sustained acceleration in carotid atherosclerotic plaque progression with intraplaque hemorrhage: a long-term time course study. JACC Cardiovasc Imaging 2012; 5(8):798-804.
15. Boussel L, Arora S, Rapp J, et al. Atherosclerotic plaque progression in carotid arteries: monitoring with high-spatial-resolution MR imaging-multicenter trial. Radiology 2009;252(3): 789-796.
16. Corti R, Fayad ZA, Fuster V, et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001;104(3):249-252.
17. Lee JM, Wiesmann F, Shirodaria C, et al. Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging. Atherosclerosis 2008;197(2):951-958.
18. Corti R, Fuster V, Fayad ZA, et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 2005; 46(1):106-112.
19. Lee JM, Robson MD, Yu LM, et al. Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol 2009; 54(19):1787-1794.
20. Corti R, Fuster V, Fayad ZA, et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 2002;106(23): 2884-2887.
21. Underhill HR, Yuan C, Zhao XQ, et al. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial. Am Heart J 2008;155(3):584.e1-e8.
22. Neuvonen PJ, Niemi M, Backman JT. Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance. Clin Pharmacol Ther 2006;80(6):565-581.
23. Li F, Yarnykh VL, Hatsukami TS, et al. Scanrescan reproducibility of carotid atherosclerotic plaque morphology and tissue composition measurements using multicontrast MRI at 3T. J Magn Reson Imaging 2010;31(1):168-176.
24. Kerwin WS, Xu D, Liu F, et al. Magnetic resonance imaging of carotid atherosclerosis: plaque analysis. Top Magn Reson Imaging 2007; 18(5):371-378.
25. Saam T, Kerwin WS, Chu BC, et al. Sample size calculation for clinical trials using magnetic resonance imaging for the quantitative assessment of carotid atherosclerosis. J Cardiovasc Magn Reson 2005;7(5):799-808.
26. Wagenknecht L, Wasserman B, Chambless L, et al. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging 2009;2(4):314-322.
27. Yuan C, Mitsumori LM, Ferguson MS, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation 2001;104(17):2051-2056.
28. Saam T, Ferguson MS, Yarnykh VL, et al. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol 2005;25(1):234-239.
29. Zhao XQ, Dong L, Hatsukami T, et al. MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. JACC Cardiovasc Imaging 2011;4(9):977-986.
30. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. New York, NY: Springer, 2000.
31. Lima JA, Desai MY, Steen H, Warren WP, Gautam S, Lai S. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 2004;110(16):2336-2341.
32. Yonemura A, Momiyama Y, Fayad ZA, et al. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J Am Coll Cardiol 2005;45(5):733-742.
33. Fayad ZA, Mani V, Woodward M, et al. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet 2011;378(9802):1547-1559.
34. Rodriguez-Granillo GA, Serruys PW, McFadden EP, et al. First-in-man prospective evaluation of temporal changes in coronary plaque composition by in vivo intravascular ultrasound radiofrequency data analysis: an Integrated Biomarker and Imaging Study (IBIS) substudy. EuroIntervention 2005;1(3):282-288.
35. Miyauchi K, Takaya N, Hirose T, et al. Rationale and design of the carotid plaque in human for all evaluations with aggressive rosuvastatin therapy (CHALLENGER trial): evaluation by magnetic resonance imaging. Circ J 2009;73(1):111-115.
36. Wasserman BA, Sharrett AR, Lai S, et al. Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the multi-ethnic study of atherosclerosis (MESA). Stroke 2008;39(2):329-335.
37. van den Bouwhuijsen QJ, Vernooij MW, Hofman A, Krestin GP, van der Lugt A, Witteman JC. Determinants of magnetic resonance imaging detected carotid plaque components: the Rotterdam Study. Eur Heart J 2012;33(2):221-229.
38. Yuan C, Kerwin WS, Ferguson MS, et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002;15(1): 62-67.
39. Wasserman BA, Smith WI, Trout HH 3rd, Cannon RO 3rd, Balaban RS, Arai AE. Carotid artery atherosclerosis: in vivo morphologic characterization with gadoliniumenhanced double-oblique MR imaging initial results. Radiology 2002;223(2):566-573.
40. Toussaint JF, LaMuraglia GM, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation 1996;94(5):932-938.
41. Trivedi RA, U-King-Im JM, Graves MJ, et al. MRI-derived measurements of fibrouscap and lipid-core thickness: the potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 2004;46(9):738-743.